Drug Companies
- All
- News
- Videos
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
- Wednesday February 11, 2026
- Health | Indo-Asian News Service
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
-
www.ndtv.com
-
Novo Nordisk Sues Telehealth Company Over 'Knock-Off' Weight Loss Drugs, Flags Patient Safety Risks
- Monday February 9, 2026
- Health | Written by Tanushka Dutta
The lawsuit, filed in the US, alleges that Hims infringed Novo Nordisk's patent by mass marketing compounded semaglutide products that have not been cleared by the US Food and Drug Administration (FDA).
-
www.ndtv.com
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
- Monday January 26, 2026
- Health | Indo-Asian News Service
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
www.ndtv.com
-
Can Non-Diabetics Take Ozempic For Weight Loss? Doctor Answers
- Friday December 12, 2025
- Health | Written by Varsha Vats
Ozempic is the brand name for a medication called semaglutide, which is primarily used to manage type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists
-
www.ndtv.com
-
New Glasses May Slow Nearsightedness In Kids After 2-Year Use
- Monday December 1, 2025
- Health | Associated Press
The US Food and Drug Administration said it cleared the lenses based on company data showing children experienced a 70% reduction in the progression of their myopia after two years.
-
www.ndtv.com
-
What Is Ozempic 2.0? All You Need To Know About New Needle-Free Weight Loss Drug
- Sunday November 30, 2025
- Lifestyle | Edited by NDTV Lifestyle Desk
The companies that manufacture Ozempic and Mounjaro are set to launch a new weight loss drug that doesn't involve needles.
-
www.ndtv.com/lifestyle
-
India To Become Global Innovation-Led Pharma Giant In 5 Years: Central Drugs Body Says
- Wednesday November 26, 2025
- Health | Indo-Asian News Service
India is well positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five years, said Dr. R Chandrashekar, Joint Drugs Controller, the Central Drugs Standard Control Organization (CDSCO).
-
www.ndtv.com
-
New Study Highlights Drug Pricing And Regulation Issues In India
- Wednesday November 12, 2025
- Health | Written by Rupashi Chhabra
A new government study exposes serious flaws in India's drug pricing and regulation infrastructure. This study reveals how systemic failures impact drug pricing.
-
www.ndtv.com
-
Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India
- Tuesday November 11, 2025
- Health | Press Trust of India
Emcure Pharma becomes the first Indian company to hold exclusive rights to distribute and commercialise Poviztra, a semaglutide injection 2.4 mg for weight loss, the statement said.
-
www.ndtv.com
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
- Wednesday February 11, 2026
- Health | Indo-Asian News Service
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
-
www.ndtv.com
-
Novo Nordisk Sues Telehealth Company Over 'Knock-Off' Weight Loss Drugs, Flags Patient Safety Risks
- Monday February 9, 2026
- Health | Written by Tanushka Dutta
The lawsuit, filed in the US, alleges that Hims infringed Novo Nordisk's patent by mass marketing compounded semaglutide products that have not been cleared by the US Food and Drug Administration (FDA).
-
www.ndtv.com
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
- Monday January 26, 2026
- Health | Indo-Asian News Service
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
www.ndtv.com
-
Can Non-Diabetics Take Ozempic For Weight Loss? Doctor Answers
- Friday December 12, 2025
- Health | Written by Varsha Vats
Ozempic is the brand name for a medication called semaglutide, which is primarily used to manage type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists
-
www.ndtv.com
-
New Glasses May Slow Nearsightedness In Kids After 2-Year Use
- Monday December 1, 2025
- Health | Associated Press
The US Food and Drug Administration said it cleared the lenses based on company data showing children experienced a 70% reduction in the progression of their myopia after two years.
-
www.ndtv.com
-
What Is Ozempic 2.0? All You Need To Know About New Needle-Free Weight Loss Drug
- Sunday November 30, 2025
- Lifestyle | Edited by NDTV Lifestyle Desk
The companies that manufacture Ozempic and Mounjaro are set to launch a new weight loss drug that doesn't involve needles.
-
www.ndtv.com/lifestyle
-
India To Become Global Innovation-Led Pharma Giant In 5 Years: Central Drugs Body Says
- Wednesday November 26, 2025
- Health | Indo-Asian News Service
India is well positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five years, said Dr. R Chandrashekar, Joint Drugs Controller, the Central Drugs Standard Control Organization (CDSCO).
-
www.ndtv.com
-
New Study Highlights Drug Pricing And Regulation Issues In India
- Wednesday November 12, 2025
- Health | Written by Rupashi Chhabra
A new government study exposes serious flaws in India's drug pricing and regulation infrastructure. This study reveals how systemic failures impact drug pricing.
-
www.ndtv.com
-
Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India
- Tuesday November 11, 2025
- Health | Press Trust of India
Emcure Pharma becomes the first Indian company to hold exclusive rights to distribute and commercialise Poviztra, a semaglutide injection 2.4 mg for weight loss, the statement said.
-
www.ndtv.com